27 completed, 4 terminated, 4 unknown, 2 recruiting. 40 Phase 1, 17 Phase 2.
Follow Epinephrine: new trials by email Literature Review of Epinephrine trials Research Report on Epinephrine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ESP Blocks in Breast Free Flaps Bupivacaine with Epinephrine and Dexamethasone - Breast Reconstruction, Free Flap Reconstruction | Phase 1 | Recruiting | Carilion Clinic | 60 | 2026-10-01 | 2026-10-23 |
| Comparative PK/PD of FMXIN002 and EpiPen, in Healthy Adults With Allergic Rhinitis FMXIN002 single dose, Epinephrine autoinjector single dose, FMXIN002 single dose + NAC - Anaphylaxis, Allergy | Phase 1 / Phase 2 | Enrolling by invitation | Nasus Pharma | 50 | 2025-11-03 | 2025-11-14 |
| PK/PD Study of IN-001 Sublingual Spray in Healthy Adults Epinephrine Auto-Injector 0.3 mg/0.3 mL, Epinephrine 0.3 mg intramuscular manual injection via a syringe and needle, IN-001 9.06 mg Sublingual Spray - Food Allergy, Anaphylaxis | Phase 1 | Completed | Insignis Therapeutics, Inc. | 32 | 2025-10-24 | 2026-05-05 |
| Effect of RECK in Posterior Spinal Fusion Ropivacaine, Epinephrine, Clonidine, and Ketorolac Injection Cocktail, Placebo - Degenerative Lumbar Spinal Stenosis, Degenerative Disc Disease | Phase 1 / Phase 2 | Withdrawn | University of Maryland, Baltimore | 2025-10-01 | 2025-07-31 | |
| COntralateral CorticoSTeroid Injection in Total Knee Arthroplasty Corticosteroid Injection - 80mg methylprednisolone (total volume 2ml) with 6 mL of 1% Bupivacaine without epinephrine (Total Volume 8 mL)., Band-Aid - Total Knee Anthroplasty, Osteoarthritis(Primary) | Phase 1 / Phase 2 | Recruiting | Unity Health Toronto | 60 | 2025-01-24 | 2026-07-30 |
| Risk of Nerve Damage After Administration of Local Anesthesia 4% Articaine with 1:200,000 epinephrine, 2% lidocaine with 1:100,000 epinephrine - Inferior Alveolar Nerve Injuries | Phase 1 | Unknown | Cleveland Dental Institute | 80 | 2024-01-01 | 2024-08-26 |
| Vasopressin vs. Epinephrine During Neonatal Cardiopulmonary Resuscitation Vasopressin, Epinephrine - Cardiac Arrest Neonatal | Phase 1 | Active not recruiting | University of Alberta | 8 | 2023-11-27 | 2026-04-09 |
| Study of Inhaled DMC-IH1 and Intramuscular (EpiPen®) Epinephrine in Healthy Male and Female Participants. Epinephrine, Placebo - Anaphylactic Reaction | Phase 1 | Completed | De Motu Cordis | 24 | 2023-10-24 | 2024-08-20 |
| Comparative Bioavailability of Intranasal Epinephrine A: Epinephrine injection, B: FMXIN002 3.6mg, C: FMXIN002 4.0mg - Anaphylaxis, Anaphylactic Reaction | Phase 1 / Phase 2 | Completed | Nasus Pharma | 12 | 2023-08-22 | 2025-06-18 |
| Evaluating Efficacy of Intravenous Carbetocin Versus Intramyometrial Injection of Adrenaline in Reducing Blood Loss Carbetocin - Uterine Fibroid | Phase 1 | Completed | Egymedicalpedia | 62 | 2023-02-01 | 2023-10-17 |
| "The Effect Of Subcutaneous Epinephrine Dosage On Blood Loss In Surgical Incision" Epinephrine injection - To Determine the Optimal Doses of Adrenaline in Preventing Blood Loos in Participants Undergoing Supraclavicular Flap Surgery | Phase 1 | Unknown | Dow University of Health Sciences | 90 | 2023-02-01 | 2023-01-04 |
| Study of Inhaled Epinephrine and Intramuscular Epinephrine Administered to Healthy Adults EpiPen ®., Epinephrine (0.3mg) inhaled, Epinephrine (1.3mg) - Anaphylactic Reaction | Phase 1 | Completed | De Motu Cordis | 23 | 2022-01-06 | 2023-07-24 |
| Pain Control Following Total Hip Arthroplasty Bupivacaine Hydrochloride 0.25% Injection Solution_#2, EPINEPHrine 1:200,000 / Prilocaine HCl 4 % 1.8 ML Cartridge, Bupivacaine Hydrochloride 0.5% Injection Solution_#2 - Chronic Postoperative Pain | Phase 1 | Completed | St. Mary's Research Center, Canada | 240 | 2021-11-04 | 2024-08-16 |
| Pharmacokinetics of Adrenaline After Administration of ARS -1 in Subjects With Upper Respiratory Tract Infection ARS-1 with URTI, ARS-1 without URTI - Upper Respiratory Tract Infection | Phase 1 | Completed | ARS Pharmaceuticals, Inc. | 15 | 2021-08-09 | 2022-07-29 |
| Bioavailability of Nasal Epinephrine Epinephrine Nasal Product, 1.6 mg, Epinephrine nasal product, 1.6 mg + allergen, Epinephrine Injection 0.3 mg - Anaphylaxis | Phase 1 | Completed | Nasus Pharma | 12 | 2020-11-01 | 2024-01-05 |
| Functional Endoscopic Sinus Surgery Study Bupivacaine or Ropivacaine with epinephrine plus dexamethasone - Group 1, Bupivacaine or Ropivacaine with epinephrine plus dexamethasone - Group 2 - Chronic Rhinosinusitis (Diagnosis) | Phase 1 / Phase 2 | Completed | University of Florida | 80 | 2019-09-25 | 2026-07-30 |
| Articaine Efficacy and Safety for Children Below Age of 4-years Articaine 4%/Epi 1:100000 Inj Cart 1.7Ml, lidocaine hydrochloride 2% and epinephrine 1:100000 - Behaviour Assessment, Pain | Phase 1 / Phase 2 | Completed | Minia University | 184 | 2019-08-25 | 2020-02-17 |
| Microneedle Pretreatment as a Strategy to Improve the Effectiveness of Topical Anesthetics Formulations Topical Anesthetic, Local anesthetic - Oral Cavity Disease | Phase 1 | Completed | University of Campinas, Brazil | 30 | 2019-08-01 | 2022-03-21 |
| Can Epinephrine Coated Syringe for Subcutaneous Immunotherapy (SCIT) Reduce Large Local Reaction? Epinephrine or normal saline - Injection Reactions Site, Systemic Reactions | Phase 1 / Phase 2 | Completed | Mahidol University | 17 | 2018-10-24 | 2020-02-20 |
| M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers M7824, Topotecan, Temozolomide - Carcinoma, Small Cell, Lung Cancer | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 37 | 2018-09-11 | 2025-05-09 |
Showing 20 of 40. Sign in to see all of them.
Anaphylaxis (6) · Asthma (4) · Agnosia (3) · Pain, Postoperative (3) · Dyspnea (2) · Lung Neoplasms (2) · Lymphoma (2) · Pain (2) · Respiratory Sounds (2) · Bronchial Spasm (1) · Carcinoma, Small Cell (1) · Dental Caries (1) · Diabetes Insipidus (1) · Disease (1) · Food Hypersensitivity (1)
Amphastar Pharmaceuticals, Inc. (4) · Nasus Pharma (3) · National Cancer Institute (NCI) (3) · De Motu Cordis (2) · Rutgers, The State University of New Jersey (2) · University of Campinas, Brazil (2) · University of Florida (2) · ARS Pharmaceuticals, Inc. (1) · Carilion Clinic (1) · Charles Berde (1) · Cleveland Dental Institute (1) · Dow University of Health Sciences (1) · Egymedicalpedia (1) · Grünenthal GmbH (1) · Insignis Therapeutics, Inc. (1)
United States (20) · Canada (4) · Australia (3) · Brazil (3) · Egypt (2) · Israel (2) · Thailand (2) · Netherlands (1) · Pakistan (1) · Sweden (1)
Siobhan Corbett, MD (2) · Ahmad Elheeny (1) · Ahmed A Hashem, PhD (1) · Alain Mina, M.D. (1) · Alice P Chen, M.D. (1) · Amir Khoshbin, MD, FRCS (C) (1) · Anders Jeppsson, MD,PhD,Prof (1) · Anish Thomas, M.D. (1) · Anthony McGirr, MD (1) · Benno von Bormann, MD (1) · Benny Weksler, MD (1) · Cameron R Smith (1) · Dr. Anthony Albers, MDCM, FRCSC (1) · Georg Schmolzer (1)
PMID 10212363, PMID 1053919, PMID 10709851, PMID 10717828, PMID 10895619, PMID 10916328, PMID 11139785, PMID 11199555, PMID 11321382, PMID 11409642, PMID 1157366, PMID 1170757, PMID 11875603, PMID 12436828, PMID 12685620, PMID 12723166, PMID 12767443, PMID 12873775, PMID 13263433, PMID 14446037, PMID 1452871, PMID 14894244, PMID 15190533, PMID 15793381, PMID 15851928, PMID 15917682, PMID 16022946, PMID 16175029, PMID 16175030, PMID 16648419, PMID 16695846, PMID 17650835, PMID 1812051, PMID 19387330, PMID 1984216, PMID 20006669, PMID 21195945, PMID 21831487, PMID 22106246, PMID 2213464, PMID 2263330, PMID 2365491, PMID 26056838, PMID 2705548, PMID 27131, PMID 30734772, PMID 30780166, PMID 3125267, PMID 3164019, PMID 32150492
2016 (1)